Larvol Delta - Camrelizumab-With-Famitinib-for-Patients-With-Rare-Head-and-Neck-Malignancies

famitinib (SHR 1020) - Jiangsu Hengrui Pharma

AiRuiKa (camrelizumab) - Elevar Therapeutics

http://clinicaltrials.gov/ct2/show/NCT07662681

Jun 24, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next